This country profile provides an overview of Cabo Verde’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
63%
Bilharzia
N/A
River blindness
N/A
86k
people received treatment in Cabo Verde in 2019
51k
people did not receive treatment in Cabo Verde in 2019
Elephantiasis
Cabo Verde does not require mass treatment for elephantiasis.
Blinding trachoma
Cabo Verde does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage decreased from 70% in 2018 to 63% in 2019.
Pre-sch and school-aged children needing treatment
137k
Pre-school and school-aged children receiving treatment
86k
Bilharzia
Cabo Verde does not require mass treatment for bilharzia.
River blindness
Cabo Verde does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Cabo Verde.